Mankind Pharma Ltd Share Price (MANKIND)
as on
| Source : NSE
Mankind Pharma Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹2,587.9₹2,651.5
0.73%
Downside
1.71%
Upside
52 Week's Low
52 Week's High
₹2,115.1₹3,054.818.86%
Downside
17.19%
Upside
| Market Stats | |
| Previous Close | ₹2,600.10 |
| Open | ₹2,588.00 |
| Volume | 7.31L |
| Upper Circuit | ₹2,860.10 |
| Lower Circuit | ₹2,340.10 |
| Day's Low | ₹2,587.9 |
| Day's High | ₹2,651.5 |
| 52 Week Low | ₹2,115.1 |
| 52 Week High | ₹3,054.8 |
| Returns % | |
| 1 Month Return | + 0.3 % |
| 3 Month Return | + 7.17 % |
| 1 Year Return | + 10.34 % |
| 3 Year Return | + 83.28 % |
| 5 Year Return | + 83.28 % |
Mankind Pharma Ltd Stock Fundamentals & Key Indicators
Check Mankind Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,07,590.13 Cr
Return on Equity (ROE)
13.89
PE Ratio (TTM)
55.96
Return on capital employed (ROCE)
14.88
Industry PE ratio
43.63
Beta (LTM)
0.65
P/B Ratio
6.83
Dividend Yield
0PEG Ratio
-23.22
Quarterly Earnings Growth YOY
-18.13
EPS (TTM)
48.74
Sector
Pharmaceuticals
Book Value
347.37
Technical Analysis
Bullish
View Technical Analysis
Mankind Pharma Ltd Stock's Interest Amongst Investors
Mankind Pharma Ltd Stock Valuation
Track how Mankind Pharma Ltd P/E has moved over time to understand its valuation trends.
Mankind Pharma Ltd in the last 5 years
Lowest (40.63x)
August 5, 2024
Industry (43.63x)
August 22, 2025
Today (55.96x)
August 22, 2025
Highest (57.89x)
July 14, 2025
Today’s Price to Earnings Ratio: 55.96x
Mankind Pharma Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Mankind Pharma Ltd.
based on 17 analysts
76.47%
Buy
11.76%
Hold
11.76%
Sell
76.47% of analysts recommend a 'BUY' rating for Mankind Pharma Ltd. Average target price of ₹2799.65
Source: S&P Global Market Intelligence
Mankind Pharma Ltd Share Price Target
Get share price movements and forecasts by analysts on Mankind Pharma Ltd.
Mankind Pharma Ltd price forecast by 17 analysts
Upside of7.40%
High
₹3300
Target
₹2799.65
Low
₹2150
Mankind Pharma Ltd target price ₹2799.65, a slight upside of 7.4% compared to current price of ₹2606.8. According to 17 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Mankind Pharma Ltd revenue growth forecast
Expected growth rate Q1, FY2027:36.00%
Forecast
Actual
Including amortisation and stock based compensations
Mankind Pharma Ltd EPS growth forecast
EPS estimate Q1, FY2027:36.37%
Forecast
Actual
Source: S&P Global Market Intelligence
Mankind Pharma Ltd Financial Results
Get the annual and quarterly financial summary of Mankind Pharma Ltd, including revenue, profit, loss and more.
Mankind Pharma Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Mankind Pharma Ltd.
Mankind Pharma Ltd Earnings Results
Mankind Pharma Ltd’s net profit fell -18.3% since last year same period to ₹438.32Cr in the Q1 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 4.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsMankind Pharma Ltd Dividends July,2025
In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.
Read More about Dividends
Indices Featuring Mankind Pharma Ltd Stock
Check stock indices that include Mankind Pharma Ltd.
Mankind Pharma Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Mankind Pharma Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.68% | ||
| Foreign Institutions | 13.07% | 1.20 | |
| Mutual Funds | 7.34% | ||
| Retail Investors | 2.75% | ||
| Others | 4.16% | 9.20 |
Mankind Pharma Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Mankind Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,07,590.13 | 16.66% | 0.69 | 2,011 | 12,207 | |
| HOLD | 1,06,626.17 | 8.57% | 0.57 | 5,725 | 32,643 | |
| HOLD | 1,63,303.00 | 17.97% | 0.50 | 2,191 | 9,360 | |
| BUY | 3,93,922.82 | 41.55% | 0.52 | 10,980 | 52,578 | |
| BUY | 1,24,721.70 | 32.68% | 0.66 | 1,911 | 11,516 |
Mankind Pharma Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Mankind Pharma Ltd.
Mankind Pharma Ltd Gains for Third Consecutive Session - 21 Aug, 2025
Mankind Pharma Ltd rose 2.96% to Rs 2580.7, marking its third consecutive gain. Despite a 3.36% drop over the past month, the stock is up 11.26% year-on-year, outperforming both NIFTY and Nifty Pharma index gains.Mankind Pharma Advances Drug Trials and Ex-Dividend Announcement - 03 Aug, 2025
Mankind Pharma is progressing with MKP10241, an oral obesity drug in Phase 2 trials, and will trade ex-dividend starting August 8, 2025.Mankind Pharma Reports Mixed Q1 FY26 Results - 01 Aug, 2025
Mankind Pharma's Q1 FY26 results show an 18.1% decline in net profit to Rs 444.6 crore, while revenue surged 24.5% to Rs 3,570 crore, indicating strong sales despite profit drop.Mankind Pharma Reports Decline in Profit Despite Revenue Growth - 31 Jul, 2025
Mankind Pharma's consolidated net profit fell 18% to Rs 438.32 crore in June 2025, despite a 24.5% increase in revenue to Rs 3,570 crore. The company also plans to raise Rs 1,000 crore and approved an interim dividend of Re 1 per share.
Insights on Mankind Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 380.23 Cr → 438.32 Cr (in ₹), with an average increase of 6.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, MANKIND stock has moved up by 5.4%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 6 quarters, 2.51K Cr → 3.65K Cr (in ₹), with an average increase of 7.1% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 12.92% to 13.07% in Jun 2025 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 7.67% to 7.34% in Jun 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 2.90% to 2.75% in Jun 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 72.70% to 72.68% in Jun 2025 quarter
About Mankind Pharma Ltd
Revenue: ₹3,570.35Cr as on June 2025 (Q1 FY26)
Net Profit: ₹444.62Cr as on June 2025 (Q1 FY26)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
| Organisation | Mankind Pharma Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| CEO | RAMESH CHAND JUNEJA |
| E-voting on shares | Click here to vote |
Mutual Funds that own Mankind Pharma Ltd Stock
Check out the Mutual Funds with significant holdings in Mankind Pharma Ltd.
FAQs
What is Mankind Pharma Ltd share price today?
Mankind Pharma Ltd share price today stands at ₹2606.8, Open: ₹2588, Previous Close: ₹2600.1, High: ₹2651.5, Low: ₹2587.9, 52 Week High: ₹3054.8, 52 Week Low: ₹2115.1 as on .
How to buy Mankind Pharma Ltd shares ?
To buy Mankind Pharma Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Mankind Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Mankind Pharma Ltd?
Today's traded volume of Mankind Pharma Ltd is 7.31L. Which means that 7.31L shares of Mankind Pharma Ltd were bought and sold on the stock market during today's trading session.
What is Mankind Pharma Ltd's market cap today?
Today's market capitalisation of Mankind Pharma Ltd is ₹1,07,590.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Mankind Pharma Ltd?
Mankind Pharma Ltd’s 52 week high is ₹3054.8 and 52 week low is ₹2115.1. The current share price of Mankind Pharma Ltd is ₹2606.8, which is -14.67% down from its 52 week high and 23.25% up from its 52 week low.